Yuichi Uemura
Papers
2
Total Citations
12
H-Index
2
About
Yuichi Uemura is a urologic surgeon and researcher whose work centers on optimizing surgical outcomes in robot-assisted radical prostatectomy and advancing treatment for aggressive bladder cancers. His most impactful study (7 citations, 2024) rigorously evaluated bleeding risks associated with thienopyridine-class antiplatelet agents—ticlopidine, clopidogrel, and prasugrel—in patients undergoing robotic prostatectomy. By leveraging a large cohort database, Uemura provided critical evidence that helps surgeons balance thrombotic protection with hemorrhagic complications, directly informing perioperative management protocols. In a complementary case report (5 citations, 2023), he documented the first successful use of Avelumab immunotherapy against multiple bone and lymph node metastases in plasmacytoid variant bladder cancer—a rare, aggressive subtype with historically poor prognosis. This work highlights Uemura’s dual focus: refining surgical safety through data-driven risk stratification and pioneering novel systemic therapies for challenging urologic malignancies. His contributions bridge operative technique and oncologic innovation, offering practical guidance for clinicians while opening new avenues for targeted treatment in resistant disease.
Research Focus
Key Achievements
Top Papers
- 1
- 2